Sort
78,016 grants matching “breast cancer”
COMMENSAL BACTERIA WITH HIGH HOMOLOGY TO NONMUTATED TUMOR ANTIGENS MAY PREVENT CLINICALLY EFFECTIVE VACCINATION IN BREAST CANCER
$659,922University Of Washington · · FY2018 · Department of the Army
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
$659,915Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2023 · MD
Multinuclear MRI to Monitor Breast Cancer Therapy
$659,883Guillaume Madelin · New York University School Of Medicine · R01 · FY2024 · CA
Density MATTERS Clinical Trial
$659,848Carrie B Hruska · Mayo Clinic Rochester · R01 · FY2021 · CA
Density MATTERS Clinical Trial
$659,848Carrie B Hruska · Mayo Clinic Rochester · R01 · FY2020 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$659,830Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline
$659,806Jeanne Mandelblatt · Georgetown University · R01 · FY2020 · AG
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
$659,732Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2022 · CA
Genomic targets of oncoproteins and tumor suppressors
$659,625Kevin Struhl · Harvard Medical School · R01 · FY2013 · CA
Brief Behavioral Intervention for Insomnia During Chemotherapy
$659,594Oxana G Palesh · Stanford University · R01 · FY2014 · CA
New Epidemiologic Methods for Reducing Measurement Error and Misclassification Bias in Cancer Epidemiology
$659,592Molin Wang · Brigham And Women'S Hospital · R01 · FY2024 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$659,547Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Functional Analysis of Breast Cancer Susceptibility Genes in Mice
$659,502Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Functional Analysis of Variants Identified in Human Breast Cancer Susceptibility
$659,502Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Insulin Resistance and Breast Cancer Prognosis in Black & White Women
$659,497Nina A Bickell · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials
$659,371Andre Rogatko · Cedars-Sinai Medical Center · U01 · FY2019 · CA
Breast Cancer Risk prediction for Hispanic women.
$659,271Mary Diaz-Santana · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Targeting posttranslational modifications of CD73 in TNBCs
$659,221Yong Wan · Northwestern University At Chicago · R01 · FY2021 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$659,220Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2023 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$659,220Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2022 · CA
The Carolina Endometrial Cancer Study: A population-based survivor cohort
$659,174Hazel B Nichols · Univ Of North Carolina Chapel Hill · U01 · FY2024 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$659,051Manish Bais · Boston University Medical Campus · R01 · FY2023 · DE
The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention
$658,980Victoria S Blinder · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
$658,974Michael T Lewis · Baylor College Of Medicine · U24 · FY2019 · CA
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$658,973Ben Shen · Scripps Florida · R01 · FY2018 · CA